The organizing committee is pleased to announce that the 4th BelTox Workshop on Non-clinical Safety Assessment of Biopharmaceuticals will take place on Friday 16 October 2015 at Ablynx, Ghent, Belgium.

The topic of this year’s meeting will be the Development of bi-specific monoclonal antibodies and antibody-drug conjugates (ADCs). The preliminary programme is now available. The format of the workshop will be similar to the previous ones; i.e. lectures by international experts in the morning and the analysis of case studies in round table discussions in the afternoon, followed by a general discussion with the audience to foster interactions. 

  Programme (129.6 KiB, 413 hits)

We would be delighted to meet you at this event. Registration is now open on the Beltox website and will be on first come-first served basis since the number of participants is limited to 70. Registration fees, including coffee breaks and lunch, are 250 € for BelTox members and 400 € for non-members.

We are convinced the workshop will provide again a unique opportunity for networking and to follow up on recent advances in biopharmaceutical drug development.

For more information and registration, please go to www.toxsoc.be